ONO-4053 Phase 2a study A multicenter, double-blind, randomized parallel-group study in patients with seasonal allergic rhinitis.
Phase of Trial: Phase II
Latest Information Update: 04 Apr 2017
At a glance
- Drugs ONO 4053 (Primary) ; Pranlukast
- Indications Seasonal allergic rhinitis
- Focus Therapeutic Use
- Sponsors Ono Pharmaceutical
- 04 Apr 2017 Results published in the Allergy Journal.
- 24 Feb 2017 Status changed from active, no longer recruiting to completed.
- 17 Mar 2016 New trial record